Last reviewed · How we verify
Therapeutic platelet transfusion
Therapeutic platelet transfusion involves administering platelets to a patient to increase their platelet count and improve blood clotting.
Therapeutic platelet transfusion involves administering platelets to a patient to increase their platelet count and improve blood clotting. Used for Thrombocytopenia, Bleeding disorders.
At a glance
| Generic name | Therapeutic platelet transfusion |
|---|---|
| Sponsor | Technische Universität Dresden |
| Modality | Biologic |
| Therapeutic area | Hematology |
| Phase | Phase 3 |
Mechanism of action
This process can help prevent or treat bleeding disorders, such as thrombocytopenia, and reduce the risk of bleeding complications in patients undergoing surgery or with certain medical conditions.
Approved indications
- Thrombocytopenia
- Bleeding disorders
Common side effects
- Bleeding
Key clinical trials
- Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide (EARLY_PHASE1)
- Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients (NA)
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease (PHASE2)
- Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) (PHASE2)
- Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children (PHASE3)
- Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA (PHASE2)
- Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Therapeutic platelet transfusion CI brief — competitive landscape report
- Therapeutic platelet transfusion updates RSS · CI watch RSS
- Technische Universität Dresden portfolio CI